1. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
   Xiaohua Zhu et al, 2017, Journal of Extracellular Vesicles CrossRef
2. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice
   Aditi Varshney et al, 2018, Hepatology CrossRef
3. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma
   Evangelista Sagnelli et al, 2018, WJH CrossRef
4. MiR-199a-3p inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via suppressing retinoblastoma 1
   Yufan Wangyang et al, 2018, Biosci. Rep. CrossRef
5. Bioinformatics analysis of regulatory elements of the CD151 gene and in silico docking of CD151 with diallyl sulfide
   Manasa Akella et al, 2019, Gene Reports CrossRef
6. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
   Guohua Lou et al, 2020, J Exp Clin Cancer Res CrossRef
7. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1
   Qiang Li et al, 2017, Oncotarget CrossRef
8. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
   Kun Zhang et al, 2020 CrossRef
9. miR‑425‑5p promotes cell proliferation, migration and invasion by directly targeting FOXD3 in hepatocellular carcinoma cells
   Hewen Wu et al, 2019, Mol Med Report CrossRef
10. TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway
    Lin Wang et al, 2018, Mol Med Report CrossRef
11. null
    Rama Rao Malla, 2020 CrossRef
12. Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses
    An-gui Liu et al, 2020, Technol Cancer Res Treat CrossRef
13. Role of Tetraspanins in Hepatocellular Carcinoma
    Sicheng Cai et al, 2021, Front. Oncol. CrossRef
14. Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy
    Behnoush Sohrabi et al, 2022, Cancer Gene Ther CrossRef
15. Integrated analysis using ToppMiR uncovers altered miRNA- mRNA regulatory networks in pediatric hepatocellular carcinoma-A pilot study.
    Senyo S Whyte et al, 2023, Cancer Rep (Hoboken) CrossRef
16. miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
    Elisa Callegari et al, 2022, Molecular Therapy - Nucleic Acids CrossRef
17. miR-199a/b-3p inhibits HCC cell proliferation and invasion through a novel compensatory signaling pathway DJ-1\Ras\PI3K/AKT
    Li-Na Ma et al, 2024, Sci Rep CrossRef
18. Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study
    Kurt Sartorius et al, 2024, IJMS CrossRef
19. The role of Tetraspanins in digestive system tumor development: update and emerging evidence
    Shijie Shao et al, 2024, Front. Cell Dev. Biol. CrossRef
20. Exposure to ambient air pollutants, serum miRNA networks, lipid metabolism, and non-alcoholic fatty liver disease in young adults
    William B. Patterson et al, 2023, Ecotoxicology and Environmental Safety CrossRef